How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

699 results for

Cardiovascular rehabilitation

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Management of stable angina

of Edinburgh Dr Morag Osborne Consultant Clinical Psychologist, West Glasgow Ambulatory Care Hospital Professor Naveed Sattar Professor of Metabolic Medicine, Institute of Cardiovascular and Medical Sciences, University of Glasgow Mr Gordon Snedden Lay representative, Forfar Professor Allan Struthers Professor of Cardiovascular Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee Dr Iain Todd Consultant in Cardiovascular Rehabilitation, Astley Ainslie Hospital, Edinburgh Management (...) to prevent new vascular events 17 4.4 Medication concordance 18 5 Interventional cardiology and cardiac surgery 19 5.1 Coronary artery anatomy and definitions 19 5.2 Percutaneous coronary intervention 19 5.3 Coronary artery bypass grafting 21 5.4 Choice of revascularisation technique 23 5.5 Postintervention drug therapy 26 5.6 Postintervention rehabilitation 28 5.7 Managing restenosis 28 5.8 Managing refractory angina 28 6 Stable angina and non-cardiac surgery 30 6.1 Assessment prior to surgery 30 6.2

2018 SIGN

142. Cardiac arrhythmias in coronary heart disease

of arrhythmias in CHD. The SIGN guideline for cardiac rehabilitation includes recommendations for all patients with CHD. 5 Together these guidelines provide a framework for managing patients across the spectrum of coronary heart disease. 1.1.1 UPDATING THE EVIDENCE This guideline updates SIGN 94: Cardiac arrhythmias in coronary heart disease, published in February 2007, to reflect the most recent evidence. Where no new evidence was identified to support an update, text and recommendations are reproduced (...) following ACS. 50,66-68 R Routine use of antiarrhythmic drugs is not recommended following ACS. Omega-3 fatty acid supplements The following text and recommendation is reproduced from SIGN 149: Risk estimation and the prevention of cardiovascular disease. 15 There is no clear evidence that increased consumption of omega-3 fats, suggested as the protective element of oily fish consumption, reduces cardiovascular disease (CVD) when consumed as supplements. In a meta- analysis of RCTs examining the effects

2018 SIGN

143. Policy on Medically-Necessary Care

by the Council on Clinical Affairs and adopted in 2007. This document is an update from the last revision in 2014. It includes an electronic search with Scopus® and PubMed®/MEDLINE using the terms: medically-necessary care, systemic disease AND oral disease, dentistry as medically-necessary care, periodontal disease AND cardiovascular disease, oral health AND pregnancy, oral health AND respiratory illness, oral health AND quality of life, pediatric dentistry general anesthesia, and nutritional deficiency (...) and well-being. Gingivitis is nearly universal in children and adolescents, and children can develop severe forms of periodontitis. 12 A relationship may exist between periodontal disease and cardiovascular disease 13-15 as well as periodontal disease and adverse pregnancy outcomes, 16,17 including pregnancy hypertension. 18 An association between oral health and respiratory diseases has been recognized. 18,19 Oral health, oral microflora, and bacterial pneumonia, especially in populations at high risk

2019 American Academy of Pediatric Dentistry

144. ESC/EACTS Guidelines on Myocardial Revascularization Full Text available with Trip Pro

Surgery Department, Hospital Santa Cruz, Avenue Prof Reynaldo dos Santos, 2790-134 Carnaxide, Portugal. Tel: + 351 210 433 163, Fax: + 351 21 424 13 88, Cardiovascular Research Centre, Department of Surgery and Physiology, Faculty of Medicine-University of Porto, Alameda Prof Hernani Monteiro, 4200-319 Porto, Portugal Email: . Search for other works by this author on: Anders Ahlsson Search for other works by this author on: Fernando Alfonso Search for other works by this author on: Adrian P Banning (...) contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) Table of contents Abbreviations and acronyms 90 1 Preamble 93 2 Introduction 94 2.1 What is new in the 2018 Guidelines? 95 3 Diagnostic tools to guide myocardial revascularization 96 3.1 Non-invasive diagnostic tools 96 3.1.1 Assessment of myocardial ischaemia 96 3.1.2 Assessment of myocardial viability in patients with heart failure and coronary artery disease 96 3.2 Invasive diagnostic tools 96 3.2.1 Pressure

2018 European Society of Cardiology

145. ESC/ESH Management of Arterial Hypertension Full Text available with Trip Pro

Article navigation 01 September 2018 Article Contents Article Navigation 2018 ESC/ESH Guidelines for the management of arterial hypertension Bryan Williams ESC Chairperson Corresponding authors. Bryan Williams, Institute of Cardiovascular Science, University College London, Maple House, 1st Floor, Suite A, 149 Tottenham Court Road, London W1T 7DN, UK, Tel: +44 (0) 20 3108 7907, E-mail: . Search for other works by this author on: Giuseppe Mancia ESH Chairperson Giuseppe Mancia, University of Milano (...) of Cardiology/European Society of Hypertension arterial hypertension Guidelines?3027 3 Definition, classification, and epidemiological aspects of hypertension3030 3.1 Definition of hypertension3030 3.2 Classification of blood pressure3030 3.3 Prevalence of hypertension3030 3.4 Blood pressure relationship with risk of cardiovascular and renal events3032 3.5 Hypertension and total cardiovascular risk assessment3032 3.6 Importance of hypertension-mediated organ damage in refining cardiovascular risk assessment

2018 European Society of Cardiology

146. Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

, practical, nutritional and rehabilitative challenges associated with cancer, patients and families continue to face significant barriers in finding and accessing these services in Ontario. Across the province there are marked variations in the delivery and availability of PSO services. Patients often do not know how or where to find help, while healthcare providers struggle to connect them with appropriate supports. Confusion about what PSO is and a lack of a cohesive identity and understanding about (...) emotional, psychological, cognitive and/ or spiritual distress have access to psychiatrists, social workers, psychologists, and/or spiritual care providers. 3.3 Patients experiencing physical, functional, rehabilitative, and/ or nutritional concerns have access to occupational therapists, physiotherapists, registered dietitians and/or speech language pathologists. 3.4 Regional Cancer Programs ensure continuity of care for all patients, regardless of where they receive their cancer treatment. 3.5

2018 Cancer Care Ontario

147. CTS guideline on pharmacotherapy in patients with COPD— 2019 update of evidence

disease measured by St. George’s respiratory disease questionnaire scores and forced expiratory volume. J Tradit Chin Med. 2014;34(4):445–449. doi: 10.1016/S0254-6272(15)30044-3. 114. Blanco I, Santos S, Gea J, et al. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J. 2013;42(4):982–992. doi:10.1183/09031936.00176312. 115. Goudie AR, Lipworth BJ, Hopkinson PJ, et al. Tadalafil in patients with chronic obstructive pulmonary disease: a rando- mised (...) JA, Dahl R, Buhl R, et al. Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients. Respir Med. 2014;108(10):1498–1507. doi:10. 1016/j.rmed.2014.07.011. 148. Calverley PMA, Anderson JA, Brook RD, et al. Fluticasone furoate, vilanterol, and lung function decline in patients with moderate chronic obstructive pulmonary disease and height- ened cardiovascular risk. Am J Respir Crit Care Med

2019 Canadian Thoracic Society

148. Management of Alcohol-Related Liver Disease

- tion over the last 20years in the UK and Finland has increased signi?cantly, while other countries such as France, Spain and Portugal were able to reduce the number of liver-related deaths. 4 Alcoholhasanimpactonover200diseasesandtypesofinju- ries. In most cases the impact is detrimental. The largest num- ber of deaths attributable to alcohol consumption are from cardiovascular diseases, followed by injuries, gastrointestinal diseases (mainly liver cirrhosis) and cancers. 5 However, the alcohol (...) or liver cirrhosis, i.e. patients presenting with bilateral parotid gland hypertrophy, muscle wasting, malnutrition, Dupuytren’s contracture, gynecomastia or extensive spider naevi. Screening for ALD should be performed in high-risk popula- tions, such as those in alcohol rehabilitations clinics, or harmful drinkers identi?ed by their GP. Screening in the workplace would be extremely helpful, although dif?cult to implement. 26 The best way to do such screening is still debatable. The Southampton traf?c

2018 European Association for the Study of the Liver

149. Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory

. ... - PREFACE The American College of Cardiology (ACC) has a long history of developing documents (e.g., decision path- ways, health policy statements, appropriate use criteria) to provide members with guidance on both clinical and nonclinicaltopicsrelevantto cardiovascular care.In most circumstances, these documents have been created to complement clinical practice guidelines and to inform clinicians about areas where evidence may be new and evolving or where suf?cient data may be more limited. In spite (...) of Hollenberg et al. JACC VOL. -,NO. -,2019 Heart Failure Hospitalization Pathway -,2019:-–- 2closely related activities, policy, mobile applications, decision support, and other tools necessary to transform care and/or improve heart health. Solution sets address key questions facing care teams and attempt to provide practical guidance to be applied at the point of care. They use both established and emerging methods to dissemi- nate information for cardiovascular conditions and their related management

2019 American College of Cardiology

150. Sudden Hearing Loss Full Text available with Trip Pro

are the target population for the therapeutic interventions that make up the bulk of the guideline update. By focusing on opportunities for quality improvement, this guideline should improve diagnostic accuracy, facilitate prompt intervention, decrease variations in management, reduce unnecessary tests and imaging procedures, and improve hearing and rehabilitative outcomes for affected patients. Methods Consistent with the American Academy of Otolaryngology–Head and Neck Surgery Foundation’s “Clinical (...) presents with sudden hearing loss. (KAS 7) Clinicians should educate patients with sudden sensorineural hearing loss about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy. (KAS 13) Clinicians should counsel patients with sudden sensorineural hearing loss who have residual hearing loss and/or tinnitus about the possible benefits of audiologic rehabilitation and other supportive measures. These strong

2019 American Academy of Otolaryngology - Head and Neck Surgery

151. Integrated care for older people (?ICOPE)?: guidance for person-centred assessment and pathways in primary care

to prevent falls. 3 93 Generic care pathway Person-centered assessment and pathways in primary care Social care and support plan Remove barriers to social participation Environmental adaptation Community-level interventions to manage declines in intrinsic capacity Understand the older person's life, values, priorities and social context Integrated management of diseases Rehabilitation Palliative and end-of-life care Reinforce generic health and lifestyle advice or usual care FOR CONDITIONS ASSOCIATED (...) and support plan Remove barriers to social participation Environmental adaptation Community-level interventions to manage declines in intrinsic capacity Understand the older person's life, values, priorities and social context Integrated management of diseases Rehabilitation Palliative and end-of-life care Reinforce generic health and lifestyle advice or usual care FOR CONDITIONS ASSOCIATED WITH LOSS IN INTRINSIC CAPACITY No loss of intrinsic capacity YES YES NO NO NO YES SCREEN FOR LOSSES IN INTRINSIC

2019 World Health Organisation Guidelines

152. Society of Interventional Radiology Training Guidelines for Endovascular Stroke Treatment Full Text available with Trip Pro

, FRCPC n , x Venu Vadlamudi Affiliations Department of Cardiovascular and Interventional Radiology, Inova Alexandria Hospital, Alexandria, Virginia , MD o , x Michael S. Webb Affiliations Department of Interventional Radiology, McKay Dee Hospital, Summit Physician Specialists, Murray, Utah , MD p , x Joan C. Wojak Affiliations Department of Radiology, Our Lady of Lourdes Regional Medical Center, Lafayette, Louisiana , MD q DOI: | Publication History Published online: September 03, 2019 Accepted (...) thrombectomy services (September 2015). Clin Radiol . 2017 ; 72 ( 175 e1–175.e9 ) ). Benchmarks for quality outcomes have been established ( x 25 Sacks, D., Baxter, B., Campbell, B.C.V. et al. Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke: From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian

2019 Society of Interventional Radiology

153. Assessment and Management of Patients at Risk for Suicide

are eligible for care in the VA and DoD healthcare delivery systems 2 See the VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Available at: 3 See the VA/DoD Clinical Practice Guideline for the Management of Concussion-mild Traumatic Brain Injury. Available at: 4 See the VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute

2019 VA/DoD Clinical Practice Guidelines

154. WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

the following working definition of self-care: Self-care is the ability of individuals, families and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a health- care provider. The scope of self-care as described in this definition includes health promotion; disease prevention and control; self-medication; providing care to dependent persons; seeking hospital/specialist/primary care if necessary; and rehabilitation, including

2019 World Health Organisation Guidelines

155. Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia

searching and in developing evidence based guidance and/or were highly familiar with the topic area. They were based in the same region to facilitate regular face-to-face meetings and allow for rapid communication between full GDG meetings. Name Job title and affiliation Writing group members Dr. Suzanne Timmons (Co-chair) Clinical Lead for the National Dementia Office; Consultant Geriatrician; Senior Lecturer in the Centre for Gerontology and Rehabilitation, University College Cork. Prof. Stephen Byrne (...) (Co-chair) Head of School of Pharmacy, University College Cork. Dr. Ashling Murphy Postdoctoral Researcher, Centre for Gerontology and Rehabilitation, University College Cork. Dr. Paul Gallagher Consultant Geriatrician, Cork University Hospital; Senior Lecturer Dept. of Medicine UCC; Irish Society of Physicians in Geriatric Medicine representative. Dr. Kieran Walsh Pharmacist; School of Pharmacy, University College Cork. Dr. Aisling Jennings General Practitioner, Kinsale; PhD candidate, Department

2019 National Clinical Guidelines (Ireland)

156. Management of Major Depressive Disorder (2nd Ediiton)

REVIEWERS (in alphabetical order) Dr. Ang Jin Kiat Senior Lecturer & Psychiatrist Universiti Putra Malaysia, Selangor Professor Dr. Anne Buist Professor of Women’s Mental Health University of Melbourne, Austin Health Australia Dr. Cheah Yee Chuang Consultant Community & Rehabilitation Psychiatrist Hospital Bahagia Ulu Kinta, Perak Professor Dr. David J. Kupfer Professor Emeritus of Psychiatry University of Pittsburgh United States of America Professor Dr. Firdaus Mukhtar Head of Department & Clinical

2019 Ministry of Health, Malaysia

157. Management of Acute ST Segment Elevation Myocardial Infarction (STEMI) – (4th Edition)

of Health (MOH). The committee members were multidisciplinary and comprised of cardiologists, internal medicine, family medicine, rehabilitation and emergency physicians from the government, private sector and universities. Relevant clinical trial data and published literature have been summarized and adapted to local practices. This guideline also implemented the work of our very own national STEMI network which links non-PCI- capable centres to PCI-capable centres so PCI services can be arranged (...) in a timely manner for all patients. Ischaemic heart disease has been a significant burden to this country, and it is projected that the burden will continue to increase with the rising number of cardiovascular risk factors and an ageing population. I believe this CPG will be an invaluable guiding document for healthcare providers involved in the management of STEMI and subsequently be translated to an improved clinical outcome for patients suffering from ischaemic heart disease. DATUK DR NOOR HISHAM

2019 Ministry of Health, Malaysia

158. Management of Heart Failure (4th Edition)

), which is now in its fourth edition. The first CPG in HF was published in 2000 with revisions in 2007 and 2014. Cardiovascular disease is an important cause of morbidity and mortality in Malaysia. HF, the end stage of most diseases of the heart, is a common medical problem encountered in clinical practice and is an important cause of hospital admissions and readmissions. It is also an important cause of hospital expenditure. Since the last CPG in 2014 the treatment modalities for the management of HF (...) , Hospital Sultanah Bahiyah Dr. Wong Kai Fatt General Practitioner, Klinik Tan, 96, Jalan Ipoh, Kuala Lumpur EXTERNAL REVIEWERS (in alphabetical Order)6 Cardiovascular disease (CVD) is an important cause of morbidity and mortality in Malaysia. Heart Failure (HF), the end stage of most diseases of the heart, is a common medical problem encountered in general practice and is an important cause of hospital admissions and readmissions. It is also an important cause of hospital expenditure. As the population

2019 Ministry of Health, Malaysia

159. Updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension Full Text available with Trip Pro

and Pediatric Cardiology, German Heart Institute Berlin (DHZB), Berlin, Germany , MD p , x Nicholas W. Morrell Affiliations Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom , MD q , x Guido Pieles Affiliations National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre, Congenital Heart Unit, Bristol Royal Hospital for Children and Bristol Heart Institute, Bristol, United Kingdom , MD, DPhil r , x (...) note that most of these variables have been validated mostly for IPAH, and the cut-off levels used above may not necessarily apply to other forms of PAH. Furthermore, the use of approved therapies and their influence on the variables should be considered in the evaluation of the risk. See also supplementary Figure S1 for the EPPVDN risk score sheet (PH risk stratification). BMI, body mass index; BNP, brain natriuretic peptide; CI, cardiac index; CMR, cardiovascular magnetic resonance imaging; e.s

2019 International Society for Heart and Lung Transplantation


Guidelines – filter by country